Bioquest Corp (BQST)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

Revenue TTM

0 15K 30K 45K Q4 '13: 0 Q1 '14: 0 Q2 '14: 0 Q3 '14: 0 Q4 '14: 0 Q1 '15: 0 Q2 '15: 29.8K Q3 '15: 31K Q4 '13 Q1 '14 Q2 '14 Q3 '14 Q4 '14 Q1 '15 Q2 '15 Q3 '15

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q4 '13: -8.3K Q1 '14: -13.1K Q2 '14: -13K Q3 '14: -11.8K Q4 '14: -123.7K Q4 '20: -356.6K Q1 '21: -661.7K Q2 '21: -1.3M Q3 '21: -1.6M Q4 '21: -2.2M Q1 '22: -2.3M Q2 '22: -1.9M Q3 '22: -1.3M Q4 '22: -817.9K Q1 '23: -403.4K Q4 '13 Q2 '14 Q4 '14 Q1 '21 Q3 '21 Q1 '22 Q3 '22 Q1 '23

Net Income TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '13: -8.3K Q1 '14: -13.1K Q2 '14: -13K Q3 '14: -10.4K Q4 '14: -488K Q1 '15: -1.6M Q2 '15: -2.5M Q3 '15: -3.4M Q4 '20: -359K Q1 '21: -663.1K Q2 '21: -1.3M Q3 '21: -1.8M Q4 '21: -2.3M Q1 '22: -2.4M Q2 '22: -2M Q3 '22: -1.3M Q4 '22: -821K Q1 '23: -507.4K Q2 '14 Q1 '15 Q4 '20 Q3 '21 Q2 '22 Q1 '23

Cost of Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow TTM

-2.4M -1.6M -800K 0 800K 1.6M 2.4M Q4 '13: -7.6K Q1 '14: -12.4K Q2 '14: -12.4K Q3 '14: -9.7K Q4 '14: -472.1K Q1 '15: -831K Q2 '15: -1.4M Q3 '15: -2.2M Q2 '21: -242.9K Q3 '21: -227.7K Q4 '21: -193.2K Q1 '22: -158.2K Q2 '22: -112.6K Q3 '22: -70.2K Q4 '22: -116.7K Q1 '23: -72.8K Q1 '14 Q3 '14 Q1 '15 Q3 '15 Q3 '21 Q1 '22 Q3 '22 Q1 '23

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 4M 8M 12M Q3 '13: 4.6M Q3 '14: 5.4M Q1 '21: 8.1M Q2 '21: 8.2M Q3 '21: 8.3M Q1 '22: 8.8M Q2 '22: 9.4M Q3 '22: 11.6M Q1 '23: 11.3M Q3 '13 Q1 '21 Q3 '21 Q2 '22 Q1 '23

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.30 -0.20 -0.10 0.00 0.10 0.20 0.30 Q4 '13: 0.00 Q1 '14: 0.00 Q2 '14: 0.00 Q3 '14: 0.00 Q4 '14: -0.01 Q1 '15: -0.03 Q2 '15: -0.04 Q3 '15: -0.05 Q4 '21: -0.28 Q1 '22: -0.29 Q2 '22: -0.23 Q3 '22: -0.15 Q4 '22: -0.09 Q1 '23: -0.05 Q1 '14 Q3 '14 Q1 '15 Q3 '15 Q1 '22 Q3 '22 Q1 '23

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.